Status:
COMPLETED
Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Diabetes
Peripheral Neuropathy
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether individuals with diabetic peripheral neuropathy can learn to change the way they walk in order to reduce the pressures underneath the feet, which may ...
Detailed Description
This study suggests that teaching a new strategy is beneficial to decrease the forefoot peak plantar pressure in individuals who are susceptible to plantar ulcerations. It has not, however, been studi...
Eligibility Criteria
Inclusion
- Diagnosis of diabetes for at least one year.
- Diabetic peripheral neuropathy as defined by failure to sense the 5.07 (10g) monofilament test in one or more of the six sites tested (31;32)
- Age 50-80 years old
- Able to ambulate independently without assistive devices (e.g. walker or crutches) (8) for 30 feet.
- No evidence of neurological (other than peripheral neuropathy) or orthopedic conditions
Exclusion
- Other non-diabetic causes of neuropathy by history
- Symptomatic peripheral vascular disease
- Joint pain, swelling and/or limited of range of motion in the lower extremities that interfere with walking or exercise
- Visual problems not correctable with glasses or contact lens
- Passive range of motion limitations are described as:
- Hip flexion \< 1000;
- Hip extension \< 200;
- Knee flexion \< 1250;
- Knee extension \< 00 (unable to obtain full extension);
- Ankle plantar flexion \< 250;
- Ankle dorsiflexion \< 150
- Other systemic or local diseases that could interfere with walking assessment
- Severe systemic diseases other than diabetes or its complications, especially those interfering with exercise tolerance
- Amputation in the lower extremities
- Terminal illness
- Severe obesity: BMI\>30 kg/m2 (33)
- Severe foot deformities (e.g. flexion contracture of the toes, pes cavus, Charcot disease)
- Mini-mental status of \<27 or diagnosis of dementia
- History of alcohol or drug abuse
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00223782
Start Date
May 1 2004
End Date
September 1 2006
Last Update
March 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, United States, 90073